Half-year report · HY
2370.TEDINET S100Y3SH
Period2025-10-01 → 2026-03-31
Filed2026-05-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 45
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥414m | 2025-10-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥810m | 2024-10-01 → 2025-09-30 | Standalone | Net sales (5-year summary) |
| Revenue | ¥405m | 2024-10-01 → 2025-03-31 | Standalone | Net sales |
| Operating income | −¥630m | 2025-10-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | −¥756m | 2024-10-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | −¥517m | 2025-10-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥1.3bn | 2024-10-01 → 2025-09-30 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥711m | 2024-10-01 → 2025-03-31 | Standalone | Ordinary income |
| Profit before tax | −¥550m | 2025-10-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥704m | 2024-10-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | −¥551m | 2025-10-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | −¥1.4bn | 2024-10-01 → 2025-09-30 | Standalone | Net income loss (5-year summary) |
| Net income | −¥706m | 2024-10-01 → 2025-03-31 | Standalone | Profit loss |
| Total assets | ¥4.0bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥4.3bn | at 2025-09-30 | Standalone | Assets |
| Total assets | ¥5.4bn | at 2025-03-31 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥413m | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥476m | at 2025-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥3.6bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.8bn | at 2025-09-30 | Standalone | Net assets |
| Net assets / equity | ¥4.4bn | at 2025-03-31 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.2bn | at 2025-09-30 | Standalone | Cash and deposits |
| Cash & equivalents | ¥2.9bn | at 2026-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.7bn | at 2025-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.4bn | at 2025-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.7bn | at 2024-09-30v | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥653m | 2025-10-01 → 2026-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.4bn | 2024-10-01 → 2025-09-30 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥754m | 2024-10-01 → 2025-03-31 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | ¥561m | 2025-10-01 → 2026-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥565m | 2024-10-01 → 2025-09-30 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.5bn | 2024-10-01 → 2025-03-31 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥350m | 2025-10-01 → 2026-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥3m | 2024-10-01 → 2025-09-30 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2m | 2024-10-01 → 2025-03-31 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-2.06 | 2025-10-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.15 | 2024-10-01 → 2025-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.67 | 2024-10-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 89.4% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.8% | at 2025-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.5% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 277,417,319 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 264,729,198 | at 2025-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 264,729,198 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2025-10-01 → 2026-03-31 | −¥279m |
| Cellular And Tissue Based Product Businessreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥276,000 |
| Cellular And Tissue Based Product Businessreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥276,000 |
| Cellular And Tissue Based Product Businessreportable segment | segment profit | 2025-10-01 → 2026-03-31 | −¥177m |
| Contract Cell Manufacturing Businessreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥414m |
| Contract Cell Manufacturing Businessreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥414m |
| Contract Cell Manufacturing Businessreportable segment | segment profit | 2025-10-01 → 2026-03-31 | −¥174m |
| —segment total | revenue | 2025-10-01 → 2026-03-31 | ¥414m |
| —segment total | revenue external | 2025-10-01 → 2026-03-31 | ¥414m |
| —segment total | segment profit | 2025-10-01 → 2026-03-31 | −¥351m |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | −¥307m |
| Cellular And Tissue Based Product Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥186,000 |
| Cellular And Tissue Based Product Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥186,000 |
| Cellular And Tissue Based Product Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥217m |
| Contract Cell Manufacturing Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥405m |
| Contract Cell Manufacturing Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥405m |
| Contract Cell Manufacturing Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥232m |
| —segment total | revenue | 2024-10-01 → 2025-03-31 | ¥405m |
| —segment total | revenue external | 2024-10-01 → 2025-03-31 | ¥405m |
| —segment total | segment profit | 2024-10-01 → 2025-03-31 | −¥448m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 468
| Item | Context | Value | Unit |
|---|---|---|---|
| Interest expenses noe | InterimDuration_NonConsolidatedMember | － | JPY |
| Foreign exchange losses noe | Prior1InterimDuration_NonConsolidatedMember | 8000 | JPY |
| Foreign exchange losses noe | InterimDuration_NonConsolidatedMember | 14000 | JPY |
| Stock issuance cost noe | Prior1InterimDuration_NonConsolidatedMember | 1514000 | JPY |
| Stock issuance cost noe | InterimDuration_NonConsolidatedMember | 1399000 | JPY |
| Bond issuance cost and warrant cost noe | Prior1InterimDuration_NonConsolidatedMember | － | JPY |
| Bond issuance cost and warrant cost noe | InterimDuration_NonConsolidatedMember | 5658000 | JPY |
| Non operating expenses | Prior1InterimDuration_NonConsolidatedMember | 1529000 | JPY |
| Non operating expenses | InterimDuration_NonConsolidatedMember | 7072000 | JPY |
| Ordinary income | Prior1InterimDuration_NonConsolidatedMember | -710835000 | JPY |
| Ordinary income | InterimDuration_NonConsolidatedMember | -516841000 | JPY |
| Gain on sales of investment securities ei | Prior1InterimDuration_NonConsolidatedMember | 7281000 | JPY |
| Gain on sales of investment securities ei | InterimDuration_NonConsolidatedMember | － | JPY |
| Extraordinary income | Prior1InterimDuration_NonConsolidatedMember | 7281000 | JPY |
| Extraordinary income | InterimDuration_NonConsolidatedMember | － | JPY |
| Loss on valuation of investment securities el | Prior1InterimDuration_NonConsolidatedMember | － | JPY |
| Loss on valuation of investment securities el | InterimDuration_NonConsolidatedMember | 33160000 | JPY |
| Extraordinary loss | Prior1InterimDuration_NonConsolidatedMember | － | JPY |
| Extraordinary loss | InterimDuration_NonConsolidatedMember | 33160000 | JPY |
| Income before income taxes | Prior1InterimDuration_NonConsolidatedMember | -703553000 | JPY |
| Income before income taxes | InterimDuration_NonConsolidatedMember | -550001000 | JPY |
| Income taxes current | Prior1InterimDuration_NonConsolidatedMember | 2105000 | JPY |
| Income taxes current | InterimDuration_NonConsolidatedMember | 1350000 | JPY |
| Income taxes | Prior1InterimDuration_NonConsolidatedMember | 2105000 | JPY |
| Income taxes | InterimDuration_NonConsolidatedMember | 1350000 | JPY |
| Profit loss | Prior1InterimDuration_NonConsolidatedMember | -705658000 | JPY |
| Profit loss | InterimDuration_NonConsolidatedMember | -551351000 | JPY |
| Income before income taxes | Prior1InterimDuration_NonConsolidatedMember | -703553000 | JPY |
| Income before income taxes | InterimDuration_NonConsolidatedMember | -550001000 | JPY |
| Depreciation and amortization ope cf | Prior1InterimDuration_NonConsolidatedMember | 49787000 | JPY |
| Depreciation and amortization ope cf | InterimDuration_NonConsolidatedMember | 47934000 | JPY |
| Share based compensation expenses ope cf | Prior1InterimDuration_NonConsolidatedMember | 3258000 | JPY |
| Share based compensation expenses ope cf | InterimDuration_NonConsolidatedMember | 3850000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1InterimDuration_NonConsolidatedMember | -1463000 | JPY |
| Increase decrease in provision for bonuses ope cf | InterimDuration_NonConsolidatedMember | -5150000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1InterimDuration_NonConsolidatedMember | -3100000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | InterimDuration_NonConsolidatedMember | -2500000 | JPY |
| Increase decrease in provision for share based payments ope cf | Prior1InterimDuration_NonConsolidatedMember | 12250000 | JPY |
| Increase decrease in provision for share based payments ope cf | InterimDuration_NonConsolidatedMember | -50623000 | JPY |
| Interest and dividends income ope cf | Prior1InterimDuration_NonConsolidatedMember | -6125000 | JPY |
| Interest and dividends income ope cf | InterimDuration_NonConsolidatedMember | -7804000 | JPY |
| Interest expenses ope cf | Prior1InterimDuration_NonConsolidatedMember | 5000 | JPY |
| Interest expenses ope cf | InterimDuration_NonConsolidatedMember | － | JPY |
| Loss gain on investments in partnership ope cf | Prior1InterimDuration_NonConsolidatedMember | -30181000 | JPY |
| Loss gain on investments in partnership ope cf | InterimDuration_NonConsolidatedMember | -103893000 | JPY |
| Stock issuance cost ope cf | Prior1InterimDuration_NonConsolidatedMember | 1514000 | JPY |
| Stock issuance cost ope cf | InterimDuration_NonConsolidatedMember | 1399000 | JPY |
| Bond issuance cost and warrant cost ope cf | Prior1InterimDuration_NonConsolidatedMember | － | JPY |
| Bond issuance cost and warrant cost ope cf | InterimDuration_NonConsolidatedMember | 5658000 | JPY |
| Loss gain on sales of investment securities ope cf | Prior1InterimDuration_NonConsolidatedMember | -7281000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |